Study: Vision loss treatment linked to higher risk of glaucoma surgery

Photo credit: Laitr Keiows

Researchers from the University of British Columbia found that patients with age-related macular degeneration who had at least 7 eye injections per year had a heightened risk of having glaucoma surgery. The team’s findings were published this week in JAMA Ophthalmology.

Patients with wet age-related macular degeneration and diabeteic macular edema, common causes of vision loss, are often treated with intravitreous injections of anti-vascular endothelial growth factor. Previous work has established that these treatments improve visual outcomes for many patients.

Get the full story at our sister site, Drug Delivery Business News.

The post Study: Vision loss treatment linked to higher risk of glaucoma surgery appeared first on MassDevice.

from MassDevice http://ift.tt/2nMJkfO